Source: Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jean-Louis Pépin (Grenoble, France). How to translate findings from experimental models into clinical studies in OSA. Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases

Member's Comments

No comment yet.

Related content which might interest you: Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020 Year: 2020 ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies Source: Virtual Congress 2020 – New developments in pandemic medicine Year: 2020 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 How to define asthma in large-scale studies? Source: International Congress 2014 – Is asthma prevalence still increasing? Year: 2014 Different methods to classify COPD patients into the ABCD severity groups – Preliminary results of the LQ-DMP project Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 A new model for clinical trials to address the COVID-19 emergency Source: Breathe, 16 (2) 200220; 10.1183/20734735.0220-2020 Year: 2020 The generalisability of the results of RCTs investigating NIV in COPD Source: International Congress 2019 – Hot topics in noninvasive ventilation Year: 2019 Is spirometry in general practice adequately performed or not? Preliminary data of an evaluation study in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 329s Year: 2001 A Markov model based on COPD disease severity to analyse the results from tiotropium trials Source: Eur Respir J 2002; 20: Suppl. 38, 125s Year: 2002 Pre-clinical models of COPD and its comorbidities Source: Annual Congress 2009 - COPD comorbidities: translational approaches Year: 2009 Ozone and COPD: a systematic map of epidemiological and experimental studies Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2012; 39: 1278-1279 Year: 2012 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2012; 39: 1277-1278 Year: 2012 Using population insight studies to define effective prevention and identification interventions in COPD Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011 Translating trials to clinical practice: results ²more real than real life itself²¹ Source: Annual Congress 2007 - Smoking cessation Year: 2007